VA
VR Adviser Portfolio holdings
AUM
$1.33B
This Quarter Return
+57.13%
1 Year Return
+6.92%
3 Year Return
+862.77%
5 Year Return
+1,580.48%
10 Year Return
–
AUM
$594M
AUM Growth
+$594M
(-8.4%)
Cap. Flow
-$56.5M
Cap. Flow
% of AUM
-9.51%
Top 10 Holdings %
Top 10 Hldgs %
70.57%
Holding
38
New
7
Increased
4
Reduced
6
Closed
10
Top Buys
| 1 |
Axsome Therapeutics
AXSM
|
$51.7M |
| 2 |
Celcuity
CELC
|
$29.5M |
| 3 |
KalVista Pharmaceuticals
KALV
|
$19.7M |
| 4 |
Novavax
NVAX
|
$19.3M |
| 5 |
Merus
MRUS
|
$19M |
Top Sells
| 1 |
TCDA
Tricida, Inc. Common Stock
TCDA
|
$94.8M |
| 2 |
Relmada Therapeutics
RLMD
|
$56.2M |
| 3 |
Gossamer Bio
GOSS
|
$20.9M |
| 4 |
Instil Bio
TIL
|
$19.9M |
| 5 |
AKUS
Akouos, Inc. Common Stock
AKUS
|
$18.9M |
Sector Composition
| 1 | Healthcare | 98.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Viridian Therapeutics
VRDN
$1.5B
| $78.9M | 13.29% | 2,699,865 +569,557 | +27% | +$16.6M |
|
2
Aclaris Therapeutics
ACRS
$209M
| $71.9M | 12.11% | 4,563,962 | – | – |
|
|
3
Axsome Therapeutics
AXSM
$6.05B
| $51.7M | 8.72% | +670,718 | New | +$51.7M |
|
4
Cogent Biosciences
COGT
$1.69B
| $46.7M | 7.86% | 4,038,117 | – | – |
|
5
Terns Pharmaceuticals
TERN
$609M
| $37.7M | 6.36% | 3,707,891 | – | – |
|
6
GH Research
GHRS
$837M
| $34.2M | 5.76% | 3,517,125 +183,971 | +6% | +$1.79M |
|
|
7
Celcuity
CELC
$2.17B
| $29.5M | 4.97% | +2,105,386 | New | +$29.5M |
|
|
DICE
8
DELISTED
DICE Therapeutics, Inc. Common Stock
DICE
| $25.6M | 4.3% | 819,000 +54,021 | +7% | +$1.69M |
|
|
JBIO
9
Jade Biosciences, Inc. Common Stock
JBIO
$258M
| $21.9M | 3.69% | 747,869 -86,058 | -10% | -$2.52M |
|
10
Pliant Therapeutics
PLRX
$101M
| $20.9M | 3.52% | 1,080,000 | – | – |
|
|
11
KalVista Pharmaceuticals
KALV
$678M
| $19.7M | 3.32% | +2,916,667 | New | +$19.7M |
|
|
12
Novavax
NVAX
$1.21B
| $19.3M | 3.26% | +1,879,894 | New | +$19.3M |
|
|
13
Merus
MRUS
$4.98B
| $19M | 3.2% | +1,226,214 | New | +$19M |
|
14
Cabaletta Bio
CABA
$133M
| $17.5M | 2.95% | +1,895,285 | New | +$17.5M |
|
15
Annexon
ANNX
$226M
| $16.6M | 2.8% | 3,220,050 | – | – |
|
|
VECT
16
DELISTED
VectivBio Holding AG Ordinary Shares
VECT
| $16.2M | 2.72% | +1,866,000 | New | +$16.2M |
|
|
PRVB
17
DELISTED
Provention Bio, Inc. Common Stock
PRVB
| $11.8M | 1.99% | 1,118,653 | – | – |
|
18
Savara
SVRA
$567M
| $9.84M | 1.66% | 6,351,531 +1,796,493 | +39% | +$2.78M |
|
19
Milestone Pharmaceuticals
MIST
$156M
| $8.75M | 1.47% | 2,208,812 -216,925 | -9% | -$859K |
|
|
LIAN
20
DELISTED
LianBio American Depositary Shares
LIAN
| $7.86M | 1.32% | 4,793,047 -585,294 | -11% | -$960K |
|
|
MRNS
21
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
| $7.05M | 1.19% | 1,770,705 -1,386,098 | -44% | -$5.52M |
|
22
Trevi Therapeutics
TRVI
$883M
| $5.89M | 0.99% | 3,050,022 | – | – |
|
23
Fulcrum Therapeutics
FULC
$351M
| $3.26M | 0.55% | 447,326 -752,674 | -63% | -$5.48M |
|
24
Lyra Therapeutics
LYRA
$11.5M
| $2.9M | 0.49% | 924,170 | – | – |
|
|
INZY
25
DELISTED
Inozyme Pharma
INZY
| $2.85M | 0.48% | 2,709,987 | – | – |
|